Primary and secondary prevention of stroke

Giuseppe Mancia, Guido Grassi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Stroke is the third leading cause of morbidity and mortality worldwide and a major cause of physical and intellectual disability, hence the need for clinically implementable strategies that lower stroke incidence and recurrence effectively and safely. Several studies have shown that stroke recurrence is closely and directly related to raised and even high-normal blood pressure, suggesting that blood pressure-lowering agents could exert a protective effect. This paper focuses on primary stroke prevention by examining the causes, risk factors, and current therapeutic approaches. It also reviews knowledge on secondary prevention and examines the potential of blood pressure-lowering drugs in this regard, with particular respect to a major recent intervention trial - Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS) - whose results demonstrate for the first time that angiotensin-converting enzyme inhibitor treatment markedly reduces stroke recurrence and prevents subsequent cognitive deterioration.

Original languageEnglish
Pages (from-to)3-11
Number of pages9
JournalDialogues in Cardiovascular Medicine
Volume8
Issue number1
Publication statusPublished - 2003

Fingerprint

Primary Prevention
Secondary Prevention
Stroke
Recurrence
Perindopril
Blood Pressure
Angiotensin-Converting Enzyme Inhibitors
Intellectual Disability
Hypertension
Morbidity
Mortality
Incidence
Therapeutics
Pharmaceutical Preparations

Keywords

  • ACE inhibitor
  • Antihypertensive treatment
  • Blood pressure
  • Cerebrovascular disease
  • Primary prevention of stroke
  • PROGRESS
  • Secondary prevention of stroke
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Primary and secondary prevention of stroke. / Mancia, Giuseppe; Grassi, Guido.

In: Dialogues in Cardiovascular Medicine, Vol. 8, No. 1, 2003, p. 3-11.

Research output: Contribution to journalArticle

@article{256a25f559974dfea0b0a957a41a84b2,
title = "Primary and secondary prevention of stroke",
abstract = "Stroke is the third leading cause of morbidity and mortality worldwide and a major cause of physical and intellectual disability, hence the need for clinically implementable strategies that lower stroke incidence and recurrence effectively and safely. Several studies have shown that stroke recurrence is closely and directly related to raised and even high-normal blood pressure, suggesting that blood pressure-lowering agents could exert a protective effect. This paper focuses on primary stroke prevention by examining the causes, risk factors, and current therapeutic approaches. It also reviews knowledge on secondary prevention and examines the potential of blood pressure-lowering drugs in this regard, with particular respect to a major recent intervention trial - Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS) - whose results demonstrate for the first time that angiotensin-converting enzyme inhibitor treatment markedly reduces stroke recurrence and prevents subsequent cognitive deterioration.",
keywords = "ACE inhibitor, Antihypertensive treatment, Blood pressure, Cerebrovascular disease, Primary prevention of stroke, PROGRESS, Secondary prevention of stroke, Stroke",
author = "Giuseppe Mancia and Guido Grassi",
year = "2003",
language = "English",
volume = "8",
pages = "3--11",
journal = "Dialogues in Cardiovascular Medicine",
issn = "1272-9949",
publisher = "Servier International",
number = "1",

}

TY - JOUR

T1 - Primary and secondary prevention of stroke

AU - Mancia, Giuseppe

AU - Grassi, Guido

PY - 2003

Y1 - 2003

N2 - Stroke is the third leading cause of morbidity and mortality worldwide and a major cause of physical and intellectual disability, hence the need for clinically implementable strategies that lower stroke incidence and recurrence effectively and safely. Several studies have shown that stroke recurrence is closely and directly related to raised and even high-normal blood pressure, suggesting that blood pressure-lowering agents could exert a protective effect. This paper focuses on primary stroke prevention by examining the causes, risk factors, and current therapeutic approaches. It also reviews knowledge on secondary prevention and examines the potential of blood pressure-lowering drugs in this regard, with particular respect to a major recent intervention trial - Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS) - whose results demonstrate for the first time that angiotensin-converting enzyme inhibitor treatment markedly reduces stroke recurrence and prevents subsequent cognitive deterioration.

AB - Stroke is the third leading cause of morbidity and mortality worldwide and a major cause of physical and intellectual disability, hence the need for clinically implementable strategies that lower stroke incidence and recurrence effectively and safely. Several studies have shown that stroke recurrence is closely and directly related to raised and even high-normal blood pressure, suggesting that blood pressure-lowering agents could exert a protective effect. This paper focuses on primary stroke prevention by examining the causes, risk factors, and current therapeutic approaches. It also reviews knowledge on secondary prevention and examines the potential of blood pressure-lowering drugs in this regard, with particular respect to a major recent intervention trial - Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS) - whose results demonstrate for the first time that angiotensin-converting enzyme inhibitor treatment markedly reduces stroke recurrence and prevents subsequent cognitive deterioration.

KW - ACE inhibitor

KW - Antihypertensive treatment

KW - Blood pressure

KW - Cerebrovascular disease

KW - Primary prevention of stroke

KW - PROGRESS

KW - Secondary prevention of stroke

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0344877320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344877320&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0344877320

VL - 8

SP - 3

EP - 11

JO - Dialogues in Cardiovascular Medicine

JF - Dialogues in Cardiovascular Medicine

SN - 1272-9949

IS - 1

ER -